Blood
About Blood
Blood is a prominent academic journal specializing in various scientific research fields. Published by American Society of Hematology in US, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is a subscription-based publication identified by ISSN 0006-4971. With a current Impact Factor of 0.849, Blood maintains rigorous standards of Peer Review and academic excellence. The journal aims to advance the boundaries of knowledge within its research areas and provides valuable insights for the global scientific community.
Editorial Perspective & Metric Analysis
Based on current metadata, Blood maintains a standard position in the US academic market. With an impact factor of 0.85, it remains a steady venue for researchers in its specific sub-fields.
Submission Tips for Blood
- Be prepared for a longer review cycle — decisions typically take around 87 days.
| ISSN (Print) | 0006-4971 |
|---|---|
| ISSN (Online) | 1528-0020 |
| Publisher | American Society of Hematology |
| Country | United States |
| APC / Cost | Inquire with Publisher |
About Blood
Blood is a prominent academic journal specializing in various scientific research fields. Published by American Society of Hematology in US, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is a subscription-based publication identified by ISSN 0006-4971. With a current impact factor of 0.849, Blood maintains rigorous standards of peer review and academic excellence. The journal aims to advance the boundaries of knowledge within its research areas and provides valuable insights for the global scientific community.
Links
Frequently Asked Questions about Blood
Live Indexing Status
Updated March 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Impact Factor
Historical Trend
Initial data points onlyImpact Factors by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.849 | Journal Citation Reports (Clarivate) |
Journal Metrics
Research Highlights
Recently published high-impact papers in this journal:
-
Imatinib and nilotinib are equally successful in achieving therapy-free remission
Fang Cheng, Yu Xin Wang, Yunfan Yang • 2026
Metadata
Last updated: Mar 20, 2026
Updated by: system